You are currently viewing a new version of our website. To view the old version click .

Histopathology and Diagnosis of Gastrointestinal Tumors

This special issue belongs to the section “Cancer Causes, Screening and Diagnosis“.

Special Issue Information

Dear Colleagues,

This Special Issue is focused on the diagnosis of gastrointestinal cancer. As the diagnosis is established by a transdisciplinary team, the aim of this Special Issue is to collect papers referring to all the examinations necessary for a proper diagnosis of common cancers but also of rare types of tumors. The diagnosis involves gastroenterologists, imagisticians, surgeons, pathologists, and geneticists but other specialists in the field might also be involved. We welcome papers that involve histopathological analysis but papers on serum examinations and new trends in preoperative diagnosis are also welcomed to be explored. The investigations carried out for the prediction of prognosis or to indicate an individualized therapy might also be part of the Special Issue. Any research or review-type papers that include data focused on diagnosis, from serum to tissue biomarkers and circulating tumor cells, are welcome. If some papers are mainly based on in silico analysis or examination of public gene databases, they should include an external validation on their own cohort. Your individual contribution to research on diagnosis tools might be helpful for doctors involved in the diagnosis of gastrointestinal tumors and provide new hope for oncologic patients.

Prof. Dr. Ioan Jung
Prof. Dr. Simona Gurzu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • histopathology
  • immunohistochemistry
  • microRNAs
  • PET-CT
  • MRI
  • gene profile
  • oncology
  • pathology
  • gastric cancer
  • colorectal cancer
  • esophageal cancer
  • cholangiocarcinoma
  • serum biomarkers

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694